SCHEMBL14256456

SCHEMBL14256456

O=[N+]([O-])c1ccccc1S(=O)(=O)N1CCN(c2nc(NC3CCCC3)c3ccccc3n2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.62
▸ MEN1 O00255 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ PKM P14618 2/20 0.62
▸ LMNA P02545 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ KDM4E B2RXH2 1/20 0.62
▸ TP53 P04637 1/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ CYP2D6 P10635 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ HPGD P15428 1/20 0.62
▸ TSHR P16473 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ HTT P42858 1/20 0.62
▸ NPSR1 Q6W5P4 1/20 0.62
▸ HSD17B10 Q99714 1/20 0.62
▸ GBA1 P04062 2/20 0.56
▸ CCR4 P51679 1/20 0.54
▸ EPHX2 P34913 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256796 0.91 ALDH1A1 (0.62) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14266665 0.84 ALDH1A1 (0.63) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256461 0.83 HSD17B10 (0.78) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256772 0.83 ALDH1A1 (0.63) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256626 0.81 KDM4E (0.77) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256519 0.81 KDM4E (0.74) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256521 0.80 CYP3A4 (0.58) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256769 0.80 KMT2A (0.61) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256553 0.79 CCR4 (0.60) ALDH1A1MEN1KMT2APKMLMNA
SCHEMBL14256631 0.75 CCR4 (0.71) ALDH1A1MEN1KMT2APKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF ALDH1A1 823/4885MEN1 913/4885KMT2A 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback